NCT07925801: Relacorilant in Patients With Poorly Controlled Type 2 Diabetes and Autonomous Cortisol Secretion
- State
- Not started
- Phase
- Phase 1 and Phase 2
- People
- 34 planned
- Started
- 1 Dec 2026
- Primary completion
- 15 Dec 2028
- Arms
- Study Investigational Drug Group
- Results
- None posted
- 9 Nov 2026: Trial registered